Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma companies will continue to push for diversity, experts say
Clinical Trials Arena
Monday, February 3, 2025 - 6:57pm
tags:
diversity, clinical trials, clinical trial diversity
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Yahoo/Reuters
Monday, February 3, 2025 - 6:55pm
tags:
Pfizer, COVID-19
Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner
Fierce Pharma
Monday, February 3, 2025 - 11:56am
tags:
Pfizer, Braftovi, FDA, colorectal cancer
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Motley Fool
Monday, February 3, 2025 - 11:55am
tags:
Novo Nordisk, obesity, amycretin
What Trump’s Second Term Could Mean for PDUFA’s Future
BioSpace
Monday, February 3, 2025 - 11:54am
tags:
FDA, PDUFA, Robert F Kennedy Jr., Donald Trump
Irish biotech's inhaled drug reduces depression in phase 2 trial
Fierce Biotech
Monday, February 3, 2025 - 11:52am
tags:
GH Research, clinical trials, depression, GH001
2021 was the leading year in rare disease trials
Clinical Trials Arena
Monday, February 3, 2025 - 11:49am
tags:
clinical trials, Rare Diseases
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Fierce Biotech
Monday, February 3, 2025 - 11:47am
tags:
Sionna Therapeutics, IPOs, cystic fibrosis
Thermo Fisher's layoff spree continues with 300 cuts in Massachusetts
Fierce Pharma
Monday, February 3, 2025 - 11:46am
tags:
Thermo Fisher, layoffs, Massachusetts
Drugmakers prep for bird flu outbreak, despite continued low risk
Pharma Voice
Monday, February 3, 2025 - 11:43am
tags:
bird flu, vaccines, H5N1, Sanofi, GSK, Seqirus
Report says AZ's UK plant decision is not just about funding
Pharmaphorum
Monday, February 3, 2025 - 11:42am
tags:
AstraZeneca, UK, funding, vaccines, drug manufacturing
J&J: CHMP gives the green light for subcutaneous Rybrevant
Marketscreener
Monday, February 3, 2025 - 11:41am
tags:
JNJ, Rybrevant, CHMP, EMA, non small cell lung cancer
US government could seek over $1 billion from J&J for cancer treatment costs
MSN/Reuters
Sunday, February 2, 2025 - 6:54pm
tags:
HHS, JNJ, legal
CDC orders pullback of new scientific papers involving its researchers, source says
Yahoo/Reuters
Sunday, February 2, 2025 - 6:53pm
tags:
CDC, scientific journals, Donald Trump
Hiroyuki Okuzawa succeeds Sunao Manabe as Daiichi Sankyo CEO
Pharmaceutical Technology
Sunday, February 2, 2025 - 6:51pm
tags:
Daiichi Sankyo, Hiroyuki Okuzawa, Sunao Manabe, Pharma CEOs
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Yahoo Finance
Friday, January 31, 2025 - 11:23am
tags:
AbbVie, earnings, Skyrizi, Rinvoq
Stymied by a federal health communications pause, journalists worry about what comes next
Poynter
Friday, January 31, 2025 - 11:21am
tags:
Public Health, communications, journalists, HHS, CDC, FDA, Donald Trump
[podcast]What to expect from the biotech IPO market in 2025
Fierce Biotech
Friday, January 31, 2025 - 11:18am
tags:
biotech, IPOs, JPMHC 2025
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Friday, January 31, 2025 - 11:16am
tags:
Eisai, Biogen, Alzheimer's disease, Leqembi, Europe
Novartis gives up on anti-CD40 antibody to treat Sjögren's due to 'benefit/risk profile'
Fierce Biotech
Friday, January 31, 2025 - 11:14am
tags:
Novartis, iscalimab, Sjögren’s syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.